K-HoriAr?)

MEMORANDUM 0 ?

FILE NAME: Talc (TALC) DATE: 1972 Apr 19 DOC#: TALC063 DOCUMENT DESCRIPTION: Letter to Barry Castleman from the FDA DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE PUBLIC HEALTH SER V ICE FOOD AND D RU G AD M IN ISTRATIO N W A S H IN G T O N , D C. 20Z04 April 19, 1972 Mr.

496 MINNESOTA MEDICINE tered regions of thickening in the capsule.

HOW TO USE THE8E SEPARATORS Use one page fo r each sep aratio n * Select appropriate tab , add fu rth e r id en tificatio n i f d e sire d , and cover it with scotch tape.

INSTRUCTIONS FOR INSERTION OF "COSMETIC TALC" STANDARD INTO CTFA STANDARDS Attached are: 1.

SUMMARY MINUTES OF THE OTC PANEL ON ANTI PERSPIRANT DRUG PRODUCTS Twelfth Meeting July 9 and 10, .1975 Parklawn Building 5600 Fishers Lane, Rockville, MD 20852 PANEL MEMBERS E.

0 H O F F MA N N - LA R O C H E INC.

s f t aJOHNS-MANVILLE RESuRCH AND ENGINEERING CENTER EXHIBIT VII VW73-62 Tate December 17, 197 MODIFIED FDA OPTICAL FOR ASBESTOS IN TALC 1.

E.

DEPARTMENT OF HEALTH & HUMAN SERVICES 8 FEB 1983 Public Heaitn Service Foo and Drug A dm inistration W ashington DC 2 0 2 0 4 Joan M.

Use, Three,' Optica ( Sysfcetus Obtain ' * Microscopic Profile Of Asbestos And Other Non-Opaque Particulates Larger Than 5 Micrometers In Parenteral Drugs \ by 'e. . .

te f c M f iw - Y ** 1954. bIES FOR THE TEAR 1955.

HHs/MG ASB^TOSIS RESEARCH COUNC^ P.O.

P THE UPJOHN COMPANY KALAMAZOO, MICHIGAN 49001 TELEPHONE (616) 382-4000 March iL, 1976 Office of HARRY R ALLEN, M D Manager, FDA Liaison Domestic Pharmaceutical Medical Affairs Hearing Clerk Food and Drug Administration Room L-65 5600 Fishers Lane Rockville, Maryland 20852 Dear Sir: In compliance with Federal Register Notice, Volume Lo, Number 51, March lL, 1975, P&ge 11865, titled "Asbestos-form Particles in Drugs for Parenteral Injection", we are supplying the attached memo.